Diebold Nixdorf, Incorporated (DBD) P/E Ratio History
ExpensiveTrading at 26.3x vs 5Y avg 16.9x · 67th percentile · Material premium to history · Data 2023–2026
Loading P/E history...
P/E Ratio Analysis
As of November 8, 2026, Diebold Nixdorf, Incorporated (DBD) trades at a price-to-earnings ratio of 26.3x, with a stock price of $58.27 and trailing twelve-month earnings per share of $2.22.
The current P/E is 55% above its 5-year average of 16.9x. Over the past five years, DBD's P/E has ranged from a low of 0.4x to a high of 41.6x, placing the current valuation at the 67th percentile of its historical range.
Compared to the Technology sector median P/E of 24.9x, DBD is roughly in line with its sector peers. The sector includes 329 companies with P/E ratios ranging from 0.0x to 185.0x.
Relative to the broader market, DBD commands a significant premium over the S&P 500 median P/E of 21.8x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our DBD DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
DBD Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
DBD P/E vs Peers
Peripherals and Printers peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $3B | 13.4 | - | +74% | |
| $2B | 21.7 | 7.69 | +15% | |
| $15B | 4.3Lowest | 0.18Best | -47% | |
| $577B | 33.7 | 1.61 | +19% | |
| $789B | 33.8 | 2.00 | +21% | |
| $12B | 23.4 | 2.11 | +12% | |
| $34B | 23.9 | 1.64 | +12% | |
| $20B | 37.3 | - | +1639%Best | |
| $3B | 34.4 | - | -64% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
DBD Historical P/E Data (2023–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q3 | Sep 30 2026 | $61.22 | $2.14 | 28.6x | +69% |
| FY2026 Q2 | - | $85.02 | $3.06 | 27.8x | +64% |
| FY2026 Q1 | - | $75.44 | $2.95 | 25.6x | +51% |
| FY2025 Q4 | Dec 31 2025 | $67.89 | $2.59 | 26.2x | +55% |
| FY2025 Q3 | - | $57.03 | $1.37 | 41.6x | +146% |
| FY2024 Q2 | Jun 30 2024 | $38.48 | $57.03 | 0.7x | -96% |
| FY2024 Q1 | Mar 31 2024 | $34.44 | $48.17 | 0.7x | -96% |
| FY2023 Q4 | Dec 31 2023 | $28.95 | $47.16 | 0.6x | -96% |
| FY2023 Q3 | Sep 30 2023 | $18.94 | $44.68 | 0.4x | -97% |
Average P/E for displayed period: 16.9x
DBD Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
3+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
DBD — Frequently Asked Questions
Quick answers to the most common questions about buying DBD stock.
What is DBD's P/E ratio?
Diebold Nixdorf, Incorporated (DBD) trailing twelve-month P/E ratio is 26.3x, based on TTM diluted EPS of $2.22. The 5-year average P/E is 16.9x and the historical range spans 0.4x to 41.6x.
Is DBD stock overvalued or undervalued?
DBD trades at 26.3x P/E, above its 5-year average of 16.9x. The 67th percentile ranking within the 0.4x–41.6x historical range indicates a premium to historical valuation.
Is DBD stock expensive?
Yes, DBD is expensive relative to its own history. The current P/E of 26.3x is above the 5-year average of 16.9x and also above the Technology sector median of 24.9x. The stock sits at the 67th percentile of its 5-year valuation range.
What is DBD's historical P/E range?
Over the past 5 years, DBD's P/E ratio has ranged from 0.4x to 41.6x, with a median of 25.6x and an average of 16.9x. The current P/E of 26.3x places the stock at the 67th percentile of this range. Full historical data spans 2023–2026.
How does DBD's P/E compare to the S&P 500?
DBD trades at 26.3x P/E versus the S&P 500 median of 21.8x. The 21% premium to the market typically reflects higher expected earnings growth or quality.
How does DBD's valuation compare to Technology peers?
Diebold Nixdorf, Incorporated P/E of 26.3x compares to the Technology sector median of 24.9x. The premium reflects expected growth above peers or stronger fundamentals. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is DBD's PEG ratio?
DBD PEG ratio is N/A, based on a P/E of 26.3x and EPS growth of 677.3%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is DBD's earnings yield?
DBD earnings yield is 3.80%, the inverse of its 26.3x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.